Plamena R. Angelova

Dr. Plamena R. Angelova

UCL Queen Square Institute of Neurology, Department of Clinical and Movement Neurosciences, University College London, WC1E 6BT, UK
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2018 in FEBS Letters
Verified
Journal Article
Closed access
PDF file
Plamena R. AngelovaPlamena R. Angelova
Plamena R. Angelova
AAANDREY Abramov
ANDREY Abramov

4 February 2021 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
WSWanyang Sun
Wanyang Sun
VTVladimir A. Tyurin
Vladimir A. Tyurin
KMKarolina Mikulska-Ruminska
Karolina Mikulska-Ruminska
ISIndira H. Shrivastava
Indira H. Shrivastava
TATamil S. Anthonymuthu
Tamil S. Anthonymuthu
VKValerian E. Kagan
Valerian E. Kagan

13 July 2020 in Medicinal Research Reviews
Verified
Journal Article
Open access
PDF file
Plamena R. AngelovaPlamena R. Angelova
Plamena R. Angelova
NENoemi Esteras
Noemi Esteras
AAANDREY Abramov
ANDREY Abramov
The world's population aging progression renders age‐related neurodegenerative diseases to be one of the biggest unsolved problems of modern society. Despite the progress in studying the development of pathology, finding ways for modifying neurodegenerative disorders remains a high priority. One common feature of neurodegenerative diseases is mitochondrial dysfunction and overproduction of reactive oxygen species, resulting in oxidative stress. Although lipid peroxidation is one of the markers for oxidative stress, it also plays an important role in cell physiology, including activation of phospholipases and stimulation of signaling cascades. Excessive lipid peroxidation is a hallmark for most neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and many other neurological conditions. The products of lipid peroxidation have been shown to be the trigger for necrotic, apoptotic, and more specifically for oxidative stress‐related, that is, ferroptosis and neuronal cell death. Here we discuss the involvement of lipid peroxidation in the mechanism of neuronal loss and some novel therapeutic directions to oppose it.

30 August 2022 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
MCMinee L. Choi
Minee L. Choi
ACAlexandre Chappard
Alexandre Chappard
BSBhanu P. Singh
Bhanu P. Singh
CMCatherine Maclachlan
Catherine Maclachlan
MRMargarida Rodrigues
Margarida Rodrigues
SGSonia Gandhi
Sonia Gandhi
Aggregation of alpha-synuclein (α-Syn) drives Parkinson’s disease (PD), although the initial stages of self-assembly and structural conversion have not been directly observed inside neurons. In this study, we tracked the intracellular conformational states of α-Syn using a single-molecule Förster resonance energy transfer (smFRET) biosensor, and we show here that α-Syn converts from a monomeric state into two distinct oligomeric states in neurons in a concentration-dependent and sequence-specific manner. Three-dimensional FRET-correlative light and electron microscopy (FRET-CLEM) revealed that intracellular seeding events occur preferentially on membrane surfaces, especially at mitochondrial membranes. The mitochondrial lipid cardiolipin triggers rapid oligomerization of A53T α-Syn, and cardiolipin is sequestered within aggregating lipid–protein complexes. Mitochondrial aggregates impair complex I activity and increase mitochondrial reactive oxygen species (ROS) generation, which accelerates the oligomerization of A53T α-Syn and causes permeabilization of mitochondrial membranes and cell death. These processes were also observed in induced pluripotent stem cell (iPSC)–derived neurons harboring A53T mutations from patients with PD. Our study highlights a mechanism of de novo α-Syn oligomerization at mitochondrial membranes and subsequent neuronal toxicity.

1 November 2016 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
Plamena R. AngelovaPlamena R. Angelova
Plamena R. Angelova
AAANDREY Abramov
ANDREY Abramov

1 March 2015 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
Plamena R. AngelovaPlamena R. Angelova
Plamena R. Angelova
MHMathew H. Horrocks
Mathew H. Horrocks
DKDavid Klenerman
David Klenerman
SGSonia Gandhi
Sonia Gandhi
AAANDREY Abramov
ANDREY Abramov
MSMikhail Shchepinov
Mikhail Shchepinov
Parkinson's disease is the second most common neurodegenerative disease and its pathogenesis is closely associated with oxidative stress. Deposition of aggregated α‐synuclein (α‐Syn) occurs in familial and sporadic forms of Parkinson's disease. Here, we studied the effect of oligomeric α‐Syn on one of the major markers of oxidative stress, lipid peroxidation, in primary co‐cultures of neurons and astrocytes. We found that oligomeric but not monomeric α‐Syn significantly increases the rate of production of reactive oxygen species, subsequently inducing lipid peroxidation in both neurons and astrocytes. Pre‐incubation of cells with isotope‐reinforced polyunsaturated fatty acids (D‐PUFAs) completely prevented the effect of oligomeric α‐Syn on lipid peroxidation. Inhibition of lipid peroxidation with D‐PUFAs further protected cells from cell death induced by oligomeric α‐Syn. Thus, lipid peroxidation induced by misfolding of α‐Syn may play an important role in the cellular mechanism of neuronal cell loss in Parkinson's disease. image We have found that aggregated α‐synuclein‐induced production of reactive oxygen species (ROS) that subsequently stimulates lipid peroxidation and cell death in neurons and astrocytes. Specific inhibition of lipid peroxidation by incubation with reinforced polyunsaturated fatty acids (D‐PUFAs) completely prevented the effect of α‐synuclein on lipid peroxidation and cell death.